Solventum Corp reported $4.8B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Abbott USD 10.46B 1.15B Jun/2026
Align Technology USD 864.87M 2.84M Jun/2026
Baxter International USD 2.68B 3.36B Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Cencora USD 77B 7.92B Mar/2026
Dexcom USD 990.1M 53.5M Jun/2026
Insulet USD 672M 32.3M Jun/2026
Solventum Corp USD 4.8B 169M Jun/2026
West Pharmaceutical Services USD 2.99B 200K Jun/2026
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026